Stockreport

NKGen Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference

NKGen Biotech, Inc.  (NKGN) 
PDF SANTA ANA, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on [Read more]